Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Immunol. 2021 Jun 16;207(1):110–114. doi: 10.4049/jimmunol.2100046

Figure 2.

Figure 2.

PD-L1 grants AMs high CTL suppression ability. (A) PD-L1-dependent repression of CD8+ T-cell activity by AMs (n ≥ 4). (B) PD-L1-dependent decrease of CD8+ T cells by AMs (n ≥ 4). Student’s t test was performed (two tailed, unpaired) and data represent means ± SEM. **P < 0.01.